{"transactions":[{"id":679921,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":21241,"kind":"person","name":"BRYNJELSEN SEAN","position":1,"cik":"0001669976","reported_name":"BRYNJELSEN SEAN","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-08-20T22:26:19.000Z","date":"2026-08-20","kind":"sale","planned":false,"acquired":false,"shares":7342,"price":62.12,"value":456085.04,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The shares were sold in multiple trades at prices ranging from $61.63 to $62.52. The price above reflects the weighted average sales price."}],"balance_after":961194,"source":{"system":"sec-edgar","filing":"0001437749-26-028651","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774926028651/rdgdoc.xml","form_type":"4"}},{"id":679920,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":21241,"kind":"person","name":"BRYNJELSEN SEAN","position":1,"cik":"0001669976","reported_name":"BRYNJELSEN SEAN","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-08-20T22:26:19.000Z","date":"2026-08-20","kind":"sale","planned":false,"acquired":false,"shares":36373,"price":61.11,"value":2222754.03,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The shares were sold in multiple trades at prices ranging from $60.61 to $61.61. The price above reflects the weighted average sales price."}],"balance_after":968536,"source":{"system":"sec-edgar","filing":"0001437749-26-028651","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774926028651/rdgdoc.xml","form_type":"4"}},{"id":679919,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":21241,"kind":"person","name":"BRYNJELSEN SEAN","position":1,"cik":"0001669976","reported_name":"BRYNJELSEN SEAN","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-08-20T22:26:19.000Z","date":"2026-08-20","kind":"sale","planned":false,"acquired":false,"shares":47307,"price":60.17,"value":2846462.19,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares were sold in multiple trades at prices ranging from $59.59 to $60.59. The price above reflects the weighted average sales price."}],"balance_after":1004909,"source":{"system":"sec-edgar","filing":"0001437749-26-028651","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774926028651/rdgdoc.xml","form_type":"4"}},{"id":679918,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":21241,"kind":"person","name":"BRYNJELSEN SEAN","position":1,"cik":"0001669976","reported_name":"BRYNJELSEN SEAN","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-08-20T22:26:19.000Z","date":"2026-08-19","kind":"sale","planned":false,"acquired":false,"shares":8978,"price":62.65,"value":562471.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in multiple trades at prices ranging from $62.50 to $63.41. The price above reflects the weighted average sales price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1052216,"source":{"system":"sec-edgar","filing":"0001437749-26-028651","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774926028651/rdgdoc.xml","form_type":"4"}},{"id":697222,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":21241,"kind":"person","name":"BRYNJELSEN SEAN","position":1,"cik":"0001669976","reported_name":"BRYNJELSEN SEAN","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-08-04T21:01:53.000Z","date":"2026-07-31","kind":"grant","planned":false,"acquired":true,"shares":128985,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On July 31, 2026, the reporting person was granted 128,985 performance-vested restricted stock units granted under the Issuer's 2018 equity incentive plan. Each restricted stock unit represents the right to acquire one share of Issuer common stock. The award vests in full, and all restrictions lapse, immediately upon the closing price of the Issuer's common stock equaling or exceeding $72.36 per share for one trading day at any time prior to the third anniversary of the grant date.  If this market condition is not satisfied prior to such date, the award will be forfeited in its entirety without consideration on July 31, 2029.The number of shares reported reflects the maximum and only number of shares issuable under the award; there is no target, threshold, or maximum range."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 31, 2026, the reporting person was granted 128,985 performance-vested restricted stock units granted under the Issuer's 2018 equity incentive plan. Each restricted stock unit represents the right to acquire one share of Issuer common stock. The award vests in full, and all restrictions lapse, immediately upon the closing price of the Issuer's common stock equaling or exceeding $72.36 per share for one trading day at any time prior to the third anniversary of the grant date.  If this market condition is not satisfied prior to such date, the award will be forfeited in its entirety without consideration on July 31, 2029.The number of shares reported reflects the maximum and only number of shares issuable under the award; there is no target, threshold, or maximum range."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 31, 2026, the reporting person was granted 128,985 performance-vested restricted stock units granted under the Issuer's 2018 equity incentive plan. Each restricted stock unit represents the right to acquire one share of Issuer common stock. The award vests in full, and all restrictions lapse, immediately upon the closing price of the Issuer's common stock equaling or exceeding $72.36 per share for one trading day at any time prior to the third anniversary of the grant date.  If this market condition is not satisfied prior to such date, the award will be forfeited in its entirety without consideration on July 31, 2029.The number of shares reported reflects the maximum and only number of shares issuable under the award; there is no target, threshold, or maximum range."}],"balance_after":128985,"derivative":{"underlying":"Common Stock","underlying_shares":128985},"source":{"system":"sec-edgar","filing":"0001437749-26-025709","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774926025709/rdgdoc.xml","form_type":"4"}},{"id":709785,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":21241,"kind":"person","name":"BRYNJELSEN SEAN","position":1,"cik":"0001669976","reported_name":"BRYNJELSEN SEAN","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Employee Stock Option","published_at":"2026-07-14T21:28:16.000Z","date":"2026-07-14","kind":"exercise","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vested annually from the date of grant (11-10-2017) in four equal installments."}],"balance_after":0,"derivative":{"exercise_price":1.37,"exercise_date":"2017-11-10","expiration_date":"2027-11-09","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001437749-26-023570","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774926023570/rdgdoc.xml","form_type":"4"}},{"id":709784,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":21241,"kind":"person","name":"BRYNJELSEN SEAN","position":1,"cik":"0001669976","reported_name":"BRYNJELSEN SEAN","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Restricted Stock Units","published_at":"2026-07-14T21:28:16.000Z","date":"2026-07-12","kind":"exercise","planned":false,"acquired":false,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 12, 2022, the reporting person was granted 110,000 restricted stock units which vested in four equal installments beginning July 12, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 12, 2022, the reporting person was granted 110,000 restricted stock units which vested in four equal installments beginning July 12, 2023."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":27500},"source":{"system":"sec-edgar","filing":"0001437749-26-023570","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774926023570/rdgdoc.xml","form_type":"4"}},{"id":709783,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":21241,"kind":"person","name":"BRYNJELSEN SEAN","position":1,"cik":"0001669976","reported_name":"BRYNJELSEN SEAN","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-07-14T21:28:16.000Z","date":"2026-07-14","kind":"exercise","planned":false,"acquired":true,"shares":200000,"price":1.37,"value":274000.0,"ownership":{"direct":true},"balance_after":1061194,"source":{"system":"sec-edgar","filing":"0001437749-26-023570","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774926023570/rdgdoc.xml","form_type":"4"}},{"id":709782,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":21241,"kind":"person","name":"BRYNJELSEN SEAN","position":1,"cik":"0001669976","reported_name":"BRYNJELSEN SEAN","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-07-14T21:28:16.000Z","date":"2026-07-12","kind":"exercise","planned":false,"acquired":true,"shares":27500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 12, 2022, the reporting person was granted 110,000 restricted stock units which vested in four equal installments beginning July 12, 2023."}],"balance_after":861194,"source":{"system":"sec-edgar","filing":"0001437749-26-023570","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774926023570/rdgdoc.xml","form_type":"4"}},{"id":758727,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":21241,"kind":"person","name":"BRYNJELSEN SEAN","position":1,"cik":"0001669976","reported_name":"BRYNJELSEN SEAN","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-05-29T20:16:53.000Z","date":"2026-05-28","kind":"sale","planned":false,"acquired":false,"shares":148,"price":32.67,"value":4835.16,"ownership":{"direct":true},"balance_after":833694,"source":{"system":"sec-edgar","filing":"0001437749-26-018879","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774926018879/rdgdoc.xml","form_type":"4"}},{"id":758726,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":21241,"kind":"person","name":"BRYNJELSEN SEAN","position":1,"cik":"0001669976","reported_name":"BRYNJELSEN SEAN","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-05-29T20:16:53.000Z","date":"2026-05-28","kind":"sale","planned":false,"acquired":false,"shares":119852,"price":31.88,"value":3820881.76,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in multiple trades at prices ranging from $31.59 to $32.55. The price above reflects the weighted average sales price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":833842,"source":{"system":"sec-edgar","filing":"0001437749-26-018879","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774926018879/rdgdoc.xml","form_type":"4"}},{"id":939233,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":21241,"kind":"person","name":"BRYNJELSEN SEAN","position":1,"cik":"0001669976","reported_name":"BRYNJELSEN SEAN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President & CEO"}}],"security":"Restricted Stock Units","published_at":"2026-01-14T23:04:50.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":100517,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of ETON Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units vest in four equal annual installments beginning January 12, 2027, contingent upon the reporting person being employed by the issuer on the date(s) of vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The restricted stock units vest in four equal annual installments beginning January 12, 2027, contingent upon the reporting person being employed by the issuer on the date(s) of vesting."}],"balance_after":3147829,"derivative":{"underlying":"Common Stock","underlying_shares":100517},"source":{"system":"sec-edgar","filing":"0001437749-26-001290","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774926001290/rdgdoc.xml","form_type":"4"}},{"id":939232,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":21241,"kind":"person","name":"BRYNJELSEN SEAN","position":1,"cik":"0001669976","reported_name":"BRYNJELSEN SEAN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-01-14T23:04:50.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":158046,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on January 12, 2030."}],"balance_after":3047312,"derivative":{"exercise_price":15.47,"expiration_date":"2036-01-11","underlying":"Common Stock","underlying_shares":158046},"source":{"system":"sec-edgar","filing":"0001437749-26-001290","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774926001290/rdgdoc.xml","form_type":"4"}},{"id":939231,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":21241,"kind":"person","name":"BRYNJELSEN SEAN","position":1,"cik":"0001669976","reported_name":"BRYNJELSEN SEAN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2026-01-14T23:04:50.000Z","date":"2026-01-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":5015,"price":15.39,"value":77180.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple trades at prices ranging from $15.39 to $15.42. The price reported above reflects the weighted average sales price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price."}],"balance_after":2889266,"source":{"system":"sec-edgar","filing":"0001437749-26-001290","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774926001290/rdgdoc.xml","form_type":"4"}},{"id":971254,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":21241,"kind":"person","name":"BRYNJELSEN SEAN","position":1,"cik":"0001669976","reported_name":"BRYNJELSEN SEAN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-12-12T21:54:41.000Z","date":"2025-12-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":6732,"price":16.83,"value":113299.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple trades at prices ranging from $16.66 to $16.98. The price reported above reflects the weighted average sales price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price."}],"balance_after":2894281,"source":{"system":"sec-edgar","filing":"0001437749-25-037741","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774925037741/rdgdoc.xml","form_type":"4"}},{"id":1121367,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":21241,"kind":"person","name":"BRYNJELSEN SEAN","position":1,"cik":"0001669976","reported_name":"BRYNJELSEN SEAN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-06-05T21:15:00.000Z","date":"2025-06-05","kind":"sale","planned":false,"acquired":false,"shares":70000,"price":16.81,"value":1176700.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The shares were sold in multiple trades at prices ranging from $16.62 to $17.15. The price reported above reflects the weighted average sales price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":2873513,"source":{"system":"sec-edgar","filing":"0001437749-25-019583","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774925019583/rdgdoc.xml","form_type":"4"}},{"id":1121366,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":21241,"kind":"person","name":"BRYNJELSEN SEAN","position":1,"cik":"0001669976","reported_name":"BRYNJELSEN SEAN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-06-05T21:15:00.000Z","date":"2025-06-04","kind":"sale","planned":false,"acquired":false,"shares":70000,"price":17,"value":1190000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The shares were sold in multiple trades at prices ranging from $16.86 to $17.20. The price reported above reflects the weighted average sales price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":2943513,"source":{"system":"sec-edgar","filing":"0001437749-25-019583","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774925019583/rdgdoc.xml","form_type":"4"}},{"id":1121365,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":21241,"kind":"person","name":"BRYNJELSEN SEAN","position":1,"cik":"0001669976","reported_name":"BRYNJELSEN SEAN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-06-05T21:15:00.000Z","date":"2025-06-03","kind":"sale","planned":false,"acquired":false,"shares":400,"price":19.02,"value":7608.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares were sold in multiple trades at a price of $19.02."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":3013513,"source":{"system":"sec-edgar","filing":"0001437749-25-019583","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774925019583/rdgdoc.xml","form_type":"4"}},{"id":1121364,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":21241,"kind":"person","name":"BRYNJELSEN SEAN","position":1,"cik":"0001669976","reported_name":"BRYNJELSEN SEAN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-06-05T21:15:00.000Z","date":"2025-06-03","kind":"sale","planned":false,"acquired":false,"shares":8655,"price":18.38,"value":159078.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple trades at prices ranging from $18.15 to $18.85. The price reported above reflects the weighted average sales price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":3013913,"source":{"system":"sec-edgar","filing":"0001437749-25-019583","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774925019583/rdgdoc.xml","form_type":"4"}},{"id":1121363,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":21241,"kind":"person","name":"BRYNJELSEN SEAN","position":1,"cik":"0001669976","reported_name":"BRYNJELSEN SEAN","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-06-05T21:15:00.000Z","date":"2025-06-03","kind":"sale","planned":false,"acquired":false,"shares":60945,"price":17.38,"value":1059224.1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in multiple trades at prices ranging from $17.00 to $17.88. The price reported above reflects the weighted average sales price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":3022568,"source":{"system":"sec-edgar","filing":"0001437749-25-019583","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774925019583/rdgdoc.xml","form_type":"4"}},{"id":1310765,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":21241,"kind":"person","name":"BRYNJELSEN SEAN","position":1,"cik":"0001669976","reported_name":"BRYNJELSEN SEAN","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Restricted Stock Units","published_at":"2025-01-06T21:18:00.000Z","date":"2025-01-03","kind":"grant","planned":false,"acquired":true,"shares":72004,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of ETON Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning January 3, 2026, contingent upon the reporting person being employed by the issuer on the date(s) of vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning January 3, 2026, contingent upon the reporting person being employed by the issuer on the date(s) of vesting."}],"balance_after":72004,"derivative":{"underlying":"Common Stock","underlying_shares":72004},"source":{"system":"sec-edgar","filing":"0001437749-25-000457","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774925000457/rdgdoc.xml","form_type":"4"}},{"id":1310764,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":21241,"kind":"person","name":"BRYNJELSEN SEAN","position":1,"cik":"0001669976","reported_name":"BRYNJELSEN SEAN","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-01-06T21:18:00.000Z","date":"2025-01-03","kind":"grant","planned":false,"acquired":true,"shares":107469,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on January 3, 2029."}],"balance_after":107469,"derivative":{"exercise_price":13,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":107469},"source":{"system":"sec-edgar","filing":"0001437749-25-000457","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774925000457/rdgdoc.xml","form_type":"4"}},{"id":1641007,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":21241,"kind":"person","name":"BRYNJELSEN SEAN","position":1,"cik":"0001669976","reported_name":"BRYNJELSEN SEAN","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to buy)","published_at":"2024-02-15T21:19:12.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":438633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on February 13, 2028."}],"balance_after":2473014,"derivative":{"exercise_price":4.42,"expiration_date":"2034-02-12","underlying":"Common Stock","underlying_shares":438633},"source":{"system":"sec-edgar","filing":"0001437749-24-004365","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000143774924004365/rdgdoc.xml","form_type":"4"}},{"id":1973884,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":21241,"kind":"person","name":"BRYNJELSEN SEAN","position":1,"cik":"0001669976","reported_name":"BRYNJELSEN SEAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to buy)","published_at":"2023-03-03T21:10:16.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":350381,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Option was approved by the Compensation Committee of the Board of Directors as of February 20, 2023 and approved by the full Board of Directors on March 3, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on February 20, 2027."}],"balance_after":1951881,"derivative":{"exercise_price":3.47,"expiration_date":"2033-02-19","underlying":"Common Stock","underlying_shares":350381},"source":{"system":"sec-edgar","filing":"0001493152-23-006671","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000149315223006671/ownership.xml","form_type":"4"}},{"id":2152031,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":21241,"kind":"person","name":"BRYNJELSEN SEAN","position":1,"cik":"0001669976","reported_name":"BRYNJELSEN SEAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-09-23T14:58:22.000Z","date":"2022-09-22","kind":"purchase","acquired":true,"shares":10000,"price":2.1042,"value":21042.0,"ownership":{"direct":true},"balance_after":1040000,"source":{"system":"sec-edgar","filing":"0001493152-22-026629","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000149315222026629/ownership.xml","form_type":"4"}},{"id":2206328,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":21241,"kind":"person","name":"BRYNJELSEN SEAN","position":1,"cik":"0001669976","reported_name":"BRYNJELSEN SEAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2022-07-18T20:36:12.000Z","date":"2022-07-12","kind":"grant","acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ETON Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning July 12, 2023, contingent upon the reporting person being employed by the issuer on the date(s) of vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning July 12, 2023, contingent upon the reporting person being employed by the issuer on the date(s) of vesting."}],"balance_after":110000,"derivative":{"underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001493152-22-019669","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000149315222019669/ownership.xml","form_type":"4"}},{"id":2369130,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":21241,"kind":"person","name":"BRYNJELSEN SEAN","position":1,"cik":"0001669976","reported_name":"BRYNJELSEN SEAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option(Right to buy)","published_at":"2022-02-28T21:27:19.000Z","date":"2022-02-07","kind":"grant","acquired":true,"shares":416500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in 24 equal monthly installments from the date of grant until fully vested and exercisable on February 7, 2024."}],"balance_after":1601500,"derivative":{"exercise_price":3.78,"expiration_date":"2032-02-07","underlying":"Common Stock","underlying_shares":416500},"source":{"system":"sec-edgar","filing":"0001493152-22-005605","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000149315222005605/ownership.xml","form_type":"4"}},{"id":2594930,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":21241,"kind":"person","name":"BRYNJELSEN SEAN","position":1,"cik":"0001669976","reported_name":"BRYNJELSEN SEAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-08-20T20:06:50.000Z","date":"2021-08-20","kind":"purchase","acquired":true,"shares":10000,"price":4.32,"value":43200.0,"ownership":{"direct":true},"balance_after":1030000,"source":{"system":"sec-edgar","filing":"0001493152-21-020807","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000149315221020807/form4.xml","form_type":"4"}},{"id":2683420,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":21241,"kind":"person","name":"BRYNJELSEN SEAN","position":1,"cik":"0001669976","reported_name":"BRYNJELSEN SEAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-06-03T16:11:06.000Z","date":"2021-06-03","kind":"purchase","acquired":true,"shares":5000,"price":5.96,"value":29800.0,"ownership":{"direct":true},"balance_after":1030000,"source":{"system":"sec-edgar","filing":"0001493152-21-013513","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000149315221013513/ownership.xml","form_type":"4"}},{"id":2727405,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":21241,"kind":"person","name":"BRYNJELSEN SEAN","position":1,"cik":"0001669976","reported_name":"BRYNJELSEN SEAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option(Right to buy)","published_at":"2021-05-05T20:16:00.000Z","date":"2021-05-03","kind":"grant","acquired":true,"shares":245000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in 24 equal monthly installments from the date of grant until fully vested and exercisable on May 3, 2023."}],"balance_after":1185000,"derivative":{"exercise_price":8.61,"expiration_date":"2031-05-03","underlying":"Common Stock","underlying_shares":245000},"source":{"system":"sec-edgar","filing":"0001493152-21-010524","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000149315221010524/ownership.xml","form_type":"4"}},{"id":3209001,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":21241,"kind":"person","name":"BRYNJELSEN SEAN","position":1,"cik":"0001669976","reported_name":"BRYNJELSEN SEAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to buy)","published_at":"2020-03-16T20:52:39.000Z","date":"2020-03-12","kind":"grant","acquired":true,"shares":490000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in 24 equal monthly installments from the date of grant until fully vested and exercisable on March 12, 2022."}],"balance_after":490000,"derivative":{"exercise_price":3.58,"expiration_date":"2030-03-11","underlying":"Common Stock","underlying_shares":490000},"source":{"system":"sec-edgar","filing":"0001493152-20-004052","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000149315220004052/ownership.xml","form_type":"4"}},{"id":3439998,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":21241,"kind":"person","name":"BRYNJELSEN SEAN","position":1,"cik":"0001669976","reported_name":"BRYNJELSEN SEAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-08-13T20:04:56.000Z","date":"2019-08-13","kind":"purchase","acquired":true,"shares":5000,"price":6.15,"value":30750.0,"ownership":{"direct":true},"balance_after":1025000,"source":{"system":"sec-edgar","filing":"0001209191-19-045738","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000120919119045738/doc4.xml","form_type":"4"}},{"id":3515446,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":21241,"kind":"person","name":"BRYNJELSEN SEAN","position":1,"cik":"0001669976","reported_name":"BRYNJELSEN SEAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-05-22T20:25:00.000Z","date":"2019-05-21","kind":"purchase","acquired":true,"shares":8600,"price":7.9571,"value":68431.06,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.90 to $8.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":1020000,"source":{"system":"sec-edgar","filing":"0001209191-19-032054","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000120919119032054/doc4.xml","form_type":"4"}},{"id":3515445,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":21241,"kind":"person","name":"BRYNJELSEN SEAN","position":1,"cik":"0001669976","reported_name":"BRYNJELSEN SEAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2019-05-22T20:25:00.000Z","date":"2019-05-20","kind":"purchase","acquired":true,"shares":1400,"price":7.782,"value":10894.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.77\nto $7.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and\nExchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set\nforth above."}],"balance_after":1011400,"source":{"system":"sec-edgar","filing":"0001209191-19-032054","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000120919119032054/doc4.xml","form_type":"4"}},{"id":3604394,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":21241,"kind":"person","name":"BRYNJELSEN SEAN","position":1,"cik":"0001669976","reported_name":"BRYNJELSEN SEAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock option (right to buy)","published_at":"2019-03-08T21:30:21.000Z","date":"2019-02-20","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in 24 equal monthly installments from the date of grant until fully vested and exercisable on February 20, 2021."}],"balance_after":250000,"derivative":{"exercise_price":7.31,"expiration_date":"2029-02-19","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001209191-19-018103","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000120919119018103/doc4.xml","form_type":"4"}},{"id":3763317,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":21241,"kind":"person","name":"BRYNJELSEN SEAN","position":1,"cik":"0001669976","reported_name":"BRYNJELSEN SEAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Series A Convertible Preferred Stock","published_at":"2018-11-16T00:23:19.000Z","date":"2018-11-15","kind":"exercise","acquired":false,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock.  The shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock.  The shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock.  The shares have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":24940},"source":{"system":"sec-edgar","filing":"0001209191-18-058826","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000120919118058826/doc4.xml","form_type":"4"}},{"id":3763316,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":21241,"kind":"person","name":"BRYNJELSEN SEAN","position":1,"cik":"0001669976","reported_name":"BRYNJELSEN SEAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2018-11-16T00:23:19.000Z","date":"2018-11-15","kind":"purchase","acquired":true,"shares":10000,"price":6,"value":60000.0,"ownership":{"direct":true},"balance_after":1010000,"source":{"system":"sec-edgar","filing":"0001209191-18-058826","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000120919118058826/doc4.xml","form_type":"4"}},{"id":3763315,"issuer":{"id":4598,"kind":"organization","name":"Eton Pharmaceuticals, Inc.","symbol":"ETON"},"owners":[{"id":21241,"kind":"person","name":"BRYNJELSEN SEAN","position":1,"cik":"0001669976","reported_name":"BRYNJELSEN SEAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2018-11-16T00:23:19.000Z","date":"2018-11-15","kind":"exercise","acquired":true,"shares":24940,"ownership":{"direct":false,"nature":"by LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock.  The shares have no expiration date."}],"balance_after":24940,"source":{"system":"sec-edgar","filing":"0001209191-18-058826","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710340/000120919118058826/doc4.xml","form_type":"4"}}]}